Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP)
NCT04630158
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
153
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Ocular Pain
Interventions
OTHER:
SAF312 Placebo
DRUG:
SAF312
Sponsor
Novartis Pharmaceuticals